REG - Abingdon Health PLC - Launch of Salistick™ saliva pregnancy test

Abingdon HealthAnnouncement

19/06/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230619:nRSS0462Da&default-theme=true

RNS Number : 0462D  Abingdon Health PLC  19 June 2023

 

Abingdon Health plc

("Abingdon Health" or "the Company")

 

Launch of Salistick™ saliva pregnancy test

Superdrug to sell Salistick™, the first ever saliva pregnancy test,
initially in 400 stores and online

Salistick™ also to launch on Abingdon Simply Test
(https://www.abingdonsimplytest.com/) website

 

York, U.K. 19 June 2023: Abingdon Health plc (AIM: ABDX), a leading
international lateral flow contract development and manufacturing organisation
(CDMO), announces the launch of Salistick™, the first-ever saliva pregnancy
test, in the UK and Ireland.

 

Salistick™ offers women an improved user experience, with high accuracy for
early pregnancy detection, by way of its revolutionary and patented saliva
technology which allows for saliva to be used as a sample rather than the
traditional urine tests. Salistick™ offers the ability to test anywhere,
anytime, and for the testing experience to be shared with a partner and other
loved ones.

 

Abingdon is the exclusive distributor of Salistick™ in the UK and Ireland on
behalf of Salignostics Ltd, an Israeli developer of innovative saliva-based
diagnostics tests. As well as providing distribution support, Abingdon has
been providing Salignostics with contract development services in scaling-up
the Salistick™ product for manufacture and will continue to provide
Salignostics with contract manufacturing services going forward.

 

Abingdon is launching Salistick™ with Superdrug, a leading health and beauty
retailer in the United Kingdom, initially rolling out into 400 stores and
online at Superdrug.com (http://www.Superdrug.com) . Superdrug trades from
almost 900 stores across the United Kingdom and Ireland.

 

In addition, Salistick™ will also launch through Abingdon's
direct-to-consumer e-commerce channel Abingdon Simply Test
(https://www.abingdonsimplytest.com/) . Salistick™ is co-branded Abingdon
Simply Test™, with the Abingdon Simply Test™ range now including over 15
self-tests. Abingdon intends to continue expanding the range of innovative
self-tests it makes available to consumers through partnering with companies
such as Salignostics Ltd to offer the very best in novel self-test technology
to the market.

 

It is estimated that 12.5 million pregnancy tests were performed in the UK in
2022((1)). The global pregnancy test kits market was valued at USD 1.70
billion in 2022 and is expected to reach USD 2.28 billion by 2028, growing at
a CAGR of 5.08%((2)).

 

Chris Yates, CEO of Abingdon Health plc, commented: "We are delighted to
announce the launch of Salistick™ initially across 400 Superdrug stores and
at Superdrug.com. This novel technology provides women with an enhanced
user-experience; offering the ability to test anywhere, anytime, and for the
experience to be shared with a partner and other loved ones. We are pleased to
have supported our partner Salignostics Ltd through the development process
into manufacturing and now commercial launch, and we look forward to deepening
our collaboration as we move forward."

 

Sources:

(1)
https://www.dailymail.co.uk/sciencetech/article-11039493/Eco-pregnancy-test-99-PAPER-promises-cut-plastic-waste-used-tests.html
(https://www.dailymail.co.uk/sciencetech/article-11039493/Eco-pregnancy-test-99-PAPER-promises-cut-plastic-waste-used-tests.html)

(2)   Pregnancy Test Kits Market Size, Share, Trends, Growth Forecast
(arizton.com)
(https://www.arizton.com/market-reports/pregnancy-test-kits-market)

 

Enquiries

 

 Abingdon Health plc                                              www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
 Chris Yates, Chief Executive Officer                             Via Walbrook PR
 Melanie Ross, Chief Financial Officer
 Chris Hand, Non-Executive Chairman

 Singer Capital Markets (Sole Broker and Nominated Adviser)       Tel: +44 (0)20 7496 3000
 Peter Steel, Alex Bond (Corporate Finance)
 Tom Salvesen (Corporate Broking)

 Walbrook PR Limited              Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
                                  (mailto:abingdon@walbrookpr.com)
 Paul McManus / Phillip Marriage  Mob: +44 (0)7980 541 893 / +44 (0)7867 984 082

 Alice Woodings                   +44 (0)7407 804 654

 

 

About Abingdon Health plc

 

Abingdon Health is a leading lateral flow contract development and
manufacturing organisation ("CDMO") offering its services to an international
customer base across industry sectors that include clinical, animal health,
plant health, and environmental testing. Abingdon Health has the internal
capabilities to take projects from initial concept through to routine and
large-scale manufacturing; from "idea to commercial success."

 

The Company's CDMO division offers product development, regulatory support,
technology transfer and manufacturing services for customers looking to
develop new assays or transfer existing laboratory-based assays to a lateral
flow format. Abingdon Health aims to support the increase in need for rapid
results across many industries and locations and produces lateral flow tests
in areas such as infectious disease, clinical testing including companion
diagnostics, animal health and environmental testing. Faster access to results
allows for rapid decision making, targeted intervention and can support better
outcomes.

 

Abingdon Health's Abingdon Simply Test range of self-tests is an ecommerce
platform that offers a range of self-tests to empowers consumers to manage
their own health and wellbeing. The Abingdon Simply Test
(http://www.abingdonsimplytest.com) ecommerce site offers consumers a range of
information to support them in making informed decisions on the tests
available. In addition, the site provides Abingdon's contract services
customers with a potential route to market for self-tests. The Abingdon Simply
Test range is also sold through international distributors and through other
channels in the UK and Ireland such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com
(http://www.abingdonhealth.com/)

 

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law
by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of
this announcement via the Regulatory Information Service, this inside
information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUNUOROBUNAAR